|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01K 67/027 | |
| C07K 14/54 | |||
| C07K 14/535 |
| (11) | Patento numeris | 3308641 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17184813.8 |
| Europos patento paraiškos padavimo data | 2013-11-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261722437 P | 2012-11-05 | US |
| (72) |
FLAVELL, Richard, US
STROWIG, Till, DE
MANZ, Markus G., CH
BORSOTTI, Chiara, US
DHODAPKAR, Madhav, US
MURPHY, Andrew J., US
STEVENS, Sean, US
YANCOPOULOS, George D., US
|
| (73) |
Yale University,
Two Whitney Avenue, New Haven, CT 06510,
US
Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US Institute for Research in Biomedicine (IRB), Via Vincenzo Vela 6, 6501 Bellinzona, CH |
| (54) | IMMUNODEFICIENT, GENETICALLY MODIFIED RODENT AND METHODS OF USE THEREOF |
| IMMUNODEFICIENT, GENETICALLY MODIFIED RODENT AND METHODS OF USE THEREOF |